Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence.
Escudero-Sanchez R, Ramos-Martínez A, Caballero-Bermejo AF, Díaz-Pollán B, Ruiz-Carrascoso G, Samperio MO, García PM, Amador PM, Romo FG, Segarra OM, Jiménez GN, Del Campo Albendea L, García AM, Cobo J.
Escudero-Sanchez R, et al. Among authors: amador pm.
Eur J Clin Microbiol Infect Dis. 2024 Mar;43(3):533-540. doi: 10.1007/s10096-024-04762-6. Epub 2024 Jan 18.
Eur J Clin Microbiol Infect Dis. 2024.
PMID: 38236366